Acp
Device Cervicothoracic
PDI 00887517996442
General payments
$1,399,914
Research payments
$139,491
Through program year 2025, $1,399,914 in general payments and $139,491 in research payments were reported against Acp (Cervicothoracic).
No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.
By program year
9 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2025 | General | $386,306 | 342 |
| 2025 | Research | $70,218 | 22 |
| 2024 | General | $268,388 | 331 |
| 2024 | Research | $42,590 | 15 |
| 2023 | General | $362,359 | 636 |
| 2023 | Research | $7,870 | 3 |
| 2022 | General | $275,347 | 478 |
| 2022 | Research | $18,813 | 7 |
| 2021 | General | $107,514 | 216 |
Breakdown
The top 5 of the 100 largest recipients; each share is of general payments naming this product in 2025.
The top 5 of 16 specialties; each share is of general payments naming this product to practitioners with a specialty in 2025. Each practitioner is counted under their primary specialty.
The top 5 of 32 states; each share is of general payments naming this product in 2025 where a state was reported.
Records
2,003 general · 47 researchEvery payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
What you are looking at
Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.